Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any aortic valve disease in which the cause of the disease is a mutation in the NOTCH1 gene.
Features include very common findings: Aortic valve calcification; and common findings: Aortic valve stenosis and Bicuspid aortic valve. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 6 | Aortic valve stenosis, Ventricular septal defect, Mitral stenosis |
Age of onset: at birth.
NOTCH1 encodes notch receptor 1 (2,555 aa). Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Highest expression in Lung (47.5 TPM) and Spleen (45.2 TPM).
Aortic valve disease 1 is associated with mutations in the NOTCH1 gene on chromosome 9.
The NOTCH1 protein participates in NOTCH1 Q2440* Transmembrane Fragment, NOTCH1 Q2395* Transmembrane Fragment, and NOTCH1 P2514Rfs*4 Transmembrane Fragment pathways.
NOTCH1 is classified as a druggable target (Cell Surface, Clinically Actionable, Druggable Genome, and Transporter categories) with score 19.6.
Genetic testing for NOTCH1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 very common feature, 2 common features.
No clinical trials have been registered for aortic valve disease 1.
12 publications have been identified in PubMed for aortic valve disease 1. Research spans Basic Science / Preclinical (42%), Case Report / Case Series (17%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 42% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 2:36 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
2 |
17% |
Disease patterns and progression | 2 | 17% |
Other research | 1 | 8% |
Research summaries | 1 | 8% |
New treatment approaches | 1 | 8% |
Chen Q (2025). [PMID: 41023825](https://pubmed.ncbi.nlm.nih.gov/41023825/). *BMC Cardiovasc Disord*. [Gene Therapy / Novel Therapeutics]
Yasuhara J (2025). [PMID: 40749336](https://pubmed.ncbi.nlm.nih.gov/40749336/). *JACC Basic Transl Sci*. [Basic Science / Preclinical]
Srivastava D (2025). [PMID: 40992827](https://pubmed.ncbi.nlm.nih.gov/40992827/). *JACC Basic Transl Sci*. [Other]
Farris J (2025). [PMID: 40420130](https://pubmed.ncbi.nlm.nih.gov/40420130/). *BMC Med Genomics*. [Case Report / Case Series]
Bruenger CMH (2025). [PMID: 40646242](https://pubmed.ncbi.nlm.nih.gov/40646242/). *Eur J Hum Genet*. [Epidemiology / Natural History]
Garoffolo G (2025). [PMID: 40962819](https://pubmed.ncbi.nlm.nih.gov/40962819/). *Signal Transduct Target Ther*. [Basic Science / Preclinical]
Sticchi E (2025). [PMID: 41515599](https://pubmed.ncbi.nlm.nih.gov/41515599/). *Diagnostics (Basel)*. [Epidemiology / Natural History]
Janin A (2025). [PMID: 40783787](https://pubmed.ncbi.nlm.nih.gov/40783787/). *HGG Adv*. [Case Report / Case Series]
Piñeiro-Sabarís R (2024). [PMID: 39057643](https://pubmed.ncbi.nlm.nih.gov/39057643/). *J Cardiovasc Dev Dis*. [Basic Science / Preclinical]
Vassiliou VS (2024). [PMID: 39457433](https://pubmed.ncbi.nlm.nih.gov/39457433/). *Genes (Basel)*. [Review / Meta-Analysis]
AI-curated news mentioning aortic valve disease 1
Updated May 18, 2026
A study identifies rare type 1 collagen variants in early-onset bicuspid aortic valve disease, revealing clinical and genetic overlaps with Ehlers-Danlos syndrome and osteogenesis imperfecta. This research enhances understanding of these connective tissue disorders.